RiverBanc Multifamily Investors, a REIT formed to own debt and equity interests in apartment communities, withdrew its plans for an initial public offering on Wednesday. In July 2015, RiverBanc filed terms for a $74 million IPO in which it would offer 3.8 million shares at a price range of $19 to $20 (market cap of $129 million), but it postponed the offering. The company had been...read more
RiverBanc Multifamily Investors, a REIT formed to own debt and equity interests in apartment communities, postponed its IPO on Thursday citing poor market conditions. Baird, Keefe Bruyette Woods, Suntrust Robinson Humphrey, Nomura Securities and Oppenheimer & Co. were set to be the joint bookrunners on the deal....read more
The largest biotech ever to go public is on the calendar for this week, targeting a $2.2 billion valuation at IPO.
Ten IPOs and two blank check companies plan to raise over $2 billion. Half are set to have a market cap of less than $200 million, and for these our ...read more
Evicted: RiverBanc Multifamily Investors officially withdraws $74 million IPO
RiverBanc Multifamily Investors, a REIT formed to own debt and equity interests in apartment communities, withdrew its plans for an initial public offering on Wednesday. In July 2015, RiverBanc filed terms for a $74 million IPO in which it would offer 3.8 million shares at a price range of $19 to $20 (market cap of $129 million), but it postponed the offering. The company had been...read more
RiverBanc Multifamily Investors postpones IPO
RiverBanc Multifamily Investors, a REIT formed to own debt and equity interests in apartment communities, postponed its IPO on Thursday citing poor market conditions. Baird, Keefe Bruyette Woods, Suntrust Robinson Humphrey, Nomura Securities and Oppenheimer & Co. were set to be the joint bookrunners on the deal....read more
Week ahead: 10 IPOs set to price during the week of August 3
August 2015 kicks off with ten IPOs on the calendar for this week - more IPOs than all of August 2014 - after a slower than average July. Based on the number of ...read more
Week ahead: 10 IPOs set to price during the week of July 27
The largest biotech ever to go public is on the calendar for this week, targeting a $2.2 billion valuation at IPO. Ten IPOs and two blank check companies plan to raise over $2 billion. Half are set to have a market cap of less than $200 million, and for these our ...read more